NCT07832526

Brief Summary

This research is studying if a community-based, community health worker (CHW) led psychosocial intervention improves hemoglobin levels among Black/African American and/or Hispanic or Latino women with anemia compared to standard of care. The intervention group will demonstrate a greater mean increase in hemoglobin at follow up than the control group. The expected treatment difference effect is a between group difference of 1.0-point or greater in mean Hgb at follow up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Sep 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Sep 2026Apr 2028

Study Start

First participant enrolled

September 1, 2026

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 22, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

1.6 years

First QC Date

September 16, 2026

Last Update Submit

September 16, 2026

Conditions

Keywords

Psychosocial interventionSurveysIron deficiency anemiaHemoglobinMenstrual healthAbnormal uterine bleeding (AUB)Community Health WorkerCommunity Based Participatory Research (CBPR)Health Education

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin levels (group level change)

    Blood samples will be obtained to measure hemoglobin levels

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

Secondary Outcomes (6)

  • Hemoglobin (Hgb) values (individual change)

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  • Self-reported hemoglobin levels

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  • Anemia status awareness

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  • Knowledge of anemia

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  • Confidence in managing anemia as measured by the Perceived Competence Scale

    Visit 1 (approximately day 1), Visit 7 (approximately day 112)

  • +1 more secondary outcomes

Study Arms (2)

Group 1-Standard of Care (SOC)

OTHER

Participants will be notified that they are anemic and receive written/verbal information on anemia and instructed to follow up with their healthcare provider (standard care)

Behavioral: Standard of Care

Group 2-SOC and Education/CHW input

OTHER

Standard care and attend a community-based series of group-based information sessions and receive support from CHW to follow up with healthcare providers about their anemia

Behavioral: Standard of CareBehavioral: Informational Series and follow-up support

Interventions

Participant will be given verbal and written information on taking iron.

Group 1-Standard of Care (SOC)Group 2-SOC and Education/CHW input

The CHW-led intervention is a structured, community-based psychosocial education series for participants randomized to the intervention arm. Trained CHWs will deliver five sessions over 10 weeks covering: (1) blood and hemoglobin basics; (2) anemia and common treatments; (3) normal menstrual health; (4) abnormal uterine bleeding (AUB), including common causes and treatments; and (5) AUB across the reproductive lifespan, with review. Sessions may be in person or use another approved, accessible modality. Standardized materials and guides will support consistency while allowing questions, discussion, and culturally responsive dialogue. CHWs will help participants understand hemoglobin results, prepare questions, connect with providers or establish care, and navigate anemia-related follow-up. CHWs will not give medical advice, diagnose conditions, or prescribe treatment.

Group 2-SOC and Education/CHW input

Eligibility Criteria

Age21 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Self-identify as black/African American and/or Hispanic/Latino
  • Has had a menstrual period in the last 6 months
  • Hemoglobin (Hgb) by point of care (POC) test is less than 12.0 g/dL and greater than or equal to 7.0 g/dL
  • Able to read, write, and communicate in Spanish and/or English

You may not qualify if:

  • Received iron infusion in the past month
  • Recent (within the last 4 weeks) or anticipated major surgery with anesthesia for greater than 30 minutes within the next 3 months
  • Undergone Bariatric (i.e. weight-loss) Surgery including Gastric Bypass Surgery, Gastric Sleeve Surgery or other Bariatric Surgery
  • Diagnosed with anemia related to a condition other than iron deficiency, such as thalassemia or sickle cell disease or are a carrier.
  • Diagnosed with cancer (not including thyroid, cervical, or non-melanoma skin cancer)
  • Currently or within the last 3 months experiencing bloody or black tarry stools
  • Currently or within the last 3 months vomiting blood or emesis that resembles dark coffee grounds
  • Currently pregnant women
  • Hgb by POC test is less than 7.0 g/dL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Community Health and Social Service Centers (CHASS)

Detroit, Michigan, 48209, United States

Location

MeSH Terms

Conditions

AnemiaAnemia, Iron-DeficiencyMetrorrhagiaHealth Education

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesAnemia, HypochromicIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesUterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Erica Marsh, MD, MSCI

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kirsten Trzeciak

CONTACT

Arthi Ramakrishnan, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Reproductive Medicine and Obstetrics and Gynecology

Study Record Dates

First Submitted

September 16, 2026

First Posted

September 22, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

April 1, 2028

Last Updated

September 22, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations